(NYSE:SHG) FLORHAM PARK, N.J.--(BUSINESS WIRE)--Shionogi Inc., a United States subsidiary of Shionogi & Co., Ltd., (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.), will share 17 scientific presentations from across its anti-infective programs at IDWeek 2025 (October 19-22, 2025) in Atlanta, Georgia. Presentations at IDWeek will feature new real-world evidence from three separate analyses from PROVE (Retrospective Cefiderocol Chart Review), the largest observational study to